top of page

Streamlining Clinical Trial Operations for a Biopharmaceutical Company: A case study

Seraphim Life Sciences was approached by a biopharmaceutical company that was struggling to manage its clinical trials. The company was conducting multiple clinical trials for a new drug but was facing challenges with slow patient recruitment, high costs, and inefficient trial management processes. Seraphim Life Sciences analyzed the company's clinical trial operations and identified several areas for improvement.

Firstly, Seraphim Life Sciences recommended implementing new technologies to streamline the clinical trial process. The company was using outdated software systems for patient enrollment, data management, and regulatory compliance. Seraphim recommended the implementation of a new electronic data capture (EDC) system to manage patient data and streamline regulatory compliance. This system would provide real-time access to patient data, reduce errors and save time in managing regulatory compliance requirements.

Secondly, Seraphim Life Sciences worked with the company to optimize patient recruitment and retention. The company was having trouble recruiting patients for its clinical trials due to poor awareness and visibility of the trials. Seraphim developed a comprehensive patient recruitment plan that included digital marketing campaigns, social media outreach, and physician referrals. The plan also included improved communication and engagement with patients throughout the clinical trial process, which helped improve patient retention.

Finally, Seraphim Life Sciences helped the company reduce costs associated with clinical trial operations. The company was overspending on trial logistics, site management, and data collection. Seraphim recommended outsourcing certain aspects of trial operations, such as site management, to reduce costs and improve efficiency. This allowed the company to focus on its core competencies and allocate resources more effectively.

The results of Seraphim Life Sciences' interventions were significant. The biopharmaceutical company was able to increase patient recruitment by 50%, reduce costs associated with trial logistics by 30%, and improve patient retention by 20%. The implementation of the EDC system also saved the company significant time and resources associated with regulatory compliance. In conclusion, Seraphim Life Sciences was able to help a biopharmaceutical company optimize its clinical trial operations and improve its overall performance. By implementing new technologies, improving patient recruitment and retention, and reducing costs, Seraphim was able to help the company achieve its clinical trial goals.


bottom of page